The museum exhibition presenting the history of the pharmaceutical plant Galychpharm was opened on the 9^th of October in Lviv. The exhibition is presented at the manufacturing site at 6/8 Opryshkivska Street/

In September 2014, Arterium Corporation launched its new product in Ukraine – Resistol. This drug is indicated for common colds and has a demonstrated efficacy for acute and chronic infections of airways and nasopharynx, bronchitis, sinusitis, tonsillitis, and rhinopharyngitis.

Arterium Corporation R&D Centre was opened in August.

The establishment of such Centre reflects the corporate strategy to improve its R&D facilities. The project took more than 10 months. The Centre has up-to-date facilities to conduct research and develop pharmaceutical products. More than 100 specialists of Analytical and Technical Labs of Arterium Corporation R&D Centre have already moved to their new workstations. Our Registration, Innovations and Clinical Trials Teams will join them in the future.

Kyiv will host the Third National Congress “Stroke and Cerebrovascular Disorders” on the 6^th – 8^th of November 2014. Arterium Corporation is a sponsor of this Congress.

May good health and professional success always be with you!

Arterium Corporation continues developing its business on foreign markets. In June 2014, Proneuro Solution for Injection and Proneuro Oral Solution were approved in the Republic of Azerbaijan.